Browse LRP2

Summary
SymbolLRP2
Namelow density lipoprotein receptor-related protein 2
Aliases gp330; megalin; Heymann nephritis antigen homolog; LRP-2; calcium sensor protein; glycoprotein 330; Low-dens ......
Chromosomal Location2q31.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Basic function annotation.
> Subcellular Location, Domain and Function
> Gene Ontology
> KEGG and Reactome Pathway
> Subcellular Location, Domain and Function
 
Subcellular Location Apical cell membrane Single-pass type I membrane protein Endosome lumen Membrane, coated pit Cell projection, dendrite Cell projection, axon Note=Localizes to brush border membranes in the kidney. In the endolymphatic sac of the inner ear, located in the lumen of endosomes as a soluble form.
Domain PF12662 Complement Clr-like EGF-like
PF07645 Calcium-binding EGF domain
PF00057 Low-density lipoprotein receptor domain class A
PF00058 Low-density lipoprotein receptor repeat class B
Function

Multiligand endocytic receptor (By similarity). Acts together with CUBN to mediate endocytosis of high-density lipoproteins (By similarity). Mediates receptor-mediated uptake of polybasic drugs such as aprotinin, aminoglycosides and polymyxin B (By similarity). In the kidney, mediates the tubular uptake and clearance of leptin (By similarity). Also mediates transport of leptin across the blood-brain barrier through endocytosis at the choroid plexus epithelium (By similarity). Endocytosis of leptin in neuronal cells is required for hypothalamic leptin signaling and leptin-mediated regulation of feeding and body weight (By similarity). Mediates endocytosis and subsequent lysosomal degradation of CST3 in kidney proximal tubule cells (By similarity). Mediates renal uptake of 25-hydroxyvitamin D3 in complex with the vitamin D3 transporter GC/DBP (By similarity). Mediates renal uptake of metallothionein-bound heavy metals (PubMed:15126248). Together with CUBN, mediates renal reabsorption of myoglobin (By similarity). Mediates renal uptake and subsequent lysosomal degradation of APOM (By similarity). Plays a role in kidney selenium homeostasis by mediating renal endocytosis of selenoprotein SEPP1 (By similarity). Mediates renal uptake of the antiapoptotic protein BIRC5/survivin which may be important for functional integrity of the kidney (PubMed:23825075). Mediates renal uptake of matrix metalloproteinase MMP2 in complex with metalloproteinase inhibitor TIMP1 (By similarity). Mediates endocytosis of Sonic hedgehog protein N-product (ShhN), the active product of SHH (By similarity). Also mediates ShhN transcytosis (By similarity). In the embryonic neuroepithelium, mediates endocytic uptake and degradation of BMP4, is required for correct SHH localization in the ventral neural tube and plays a role in patterning of the ventral telencephalon (By similarity). Required at the onset of neurulation to sequester SHH on the apical surface of neuroepithelial cells of the rostral diencephalon ventral midline and to control PTCH1-dependent uptake and intracellular trafficking of SHH (By similarity). During neurulation, required in neuroepithelial cells for uptake of folate bound to the folate receptor FOLR1 which is necessary for neural tube closure (By similarity). In the adult brain, negatively regulates BMP signaling in the subependymal zone which enables neurogenesis to proceed (By similarity). In astrocytes, mediates endocytosis of ALB which is required for the synthesis of the neurotrophic factor oleic acid (By similarity). Involved in neurite branching (By similarity). During optic nerve development, required for SHH-mediated migration and proliferation of oligodendrocyte precursor cells (By similarity). Mediates endocytic uptake and clearance of SHH in the retinal margin which protects retinal progenitor cells from mitogenic stimuli and keeps them quiescent (By similarity). Plays a role in reproductive organ development by mediating uptake in reproductive tissues of androgen and estrogen bound to the sex hormone binding protein SHBG (By similarity). Mediates endocytosis of angiotensin-2 (By similarity). Also mediates endocytosis of angiotensis 1-7 (By similarity). Binds to the complex composed of beta-amyloid protein 40 and CLU/APOJ and mediates its endocytosis and lysosomal degradation (By similarity). Required for embryonic heart development (By similarity). Required for normal hearing, possibly through interaction with estrogen in the inner ear (By similarity).

> Gene Ontology
 
Biological Process GO:0001523 retinoid metabolic process
GO:0003205 cardiac chamber development
GO:0003231 cardiac ventricle development
GO:0003279 cardiac septum development
GO:0003281 ventricular septum development
GO:0006486 protein glycosylation
GO:0006720 isoprenoid metabolic process
GO:0006721 terpenoid metabolic process
GO:0006766 vitamin metabolic process
GO:0006775 fat-soluble vitamin metabolic process
GO:0006898 receptor-mediated endocytosis
GO:0007507 heart development
GO:0008202 steroid metabolic process
GO:0009100 glycoprotein metabolic process
GO:0009101 glycoprotein biosynthetic process
GO:0016101 diterpenoid metabolic process
GO:0030900 forebrain development
GO:0035904 aorta development
GO:0042359 vitamin D metabolic process
GO:0042953 lipoprotein transport
GO:0043413 macromolecule glycosylation
GO:0044872 lipoprotein localization
GO:0060840 artery development
GO:0060976 coronary vasculature development
GO:0070085 glycosylation
GO:1901615 organic hydroxy compound metabolic process
Molecular Function GO:0005041 low-density lipoprotein receptor activity
GO:0017124 SH3 domain binding
GO:0030228 lipoprotein particle receptor activity
GO:0038024 cargo receptor activity
GO:0042954 lipoprotein transporter activity
Cellular Component GO:0005765 lysosomal membrane
GO:0005903 brush border
GO:0005905 clathrin-coated pit
GO:0016324 apical plasma membrane
GO:0030139 endocytic vesicle
GO:0031253 cell projection membrane
GO:0031526 brush border membrane
GO:0043235 receptor complex
GO:0045177 apical part of cell
GO:0098589 membrane region
GO:0098852 lytic vacuole membrane
GO:0098862 cluster of actin-based cell projections
> KEGG and Reactome Pathway
 
KEGG hsa04340 Hedgehog signaling pathway
hsa04918 Thyroid hormone synthesis
Reactome R-HSA-8856825: Cargo recognition for clathrin-mediated endocytosis
R-HSA-8856828: Clathrin-mediated endocytosis
R-HSA-199991: Membrane Trafficking
R-HSA-1430728: Metabolism
R-HSA-6806667: Metabolism of fat-soluble vitamins
R-HSA-196854: Metabolism of vitamins and cofactors
R-HSA-975634: Retinoid metabolism and transport
R-HSA-162582: Signal Transduction
R-HSA-209943: Steroid hormones
R-HSA-5653656: Vesicle-mediated transport
R-HSA-2187338: Visual phototransduction
R-HSA-196791: Vitamin D (calciferol) metabolism
Summary
SymbolLRP2
Namelow density lipoprotein receptor-related protein 2
Aliases gp330; megalin; Heymann nephritis antigen homolog; LRP-2; calcium sensor protein; glycoprotein 330; Low-dens ......
Chromosomal Location2q31.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Literatures that report relations between LRP2 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells.
> Text Mining
 

There is no record.

Summary
SymbolLRP2
Namelow density lipoprotein receptor-related protein 2
Aliases gp330; megalin; Heymann nephritis antigen homolog; LRP-2; calcium sensor protein; glycoprotein 330; Low-dens ......
Chromosomal Location2q31.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets.
> High-throughput Screening
  Statistical results of LRP2 in screening data sets for detecting immune reponses.
PMID Screening System Cancer Type Cell Line Data Set Statistical Results Relation to immunity
29301958CRISPR-Cas9 melanomaB16F10Pmel-1 T cell NA/NSNA/NS
29301958CRISPR-Cas9 melanomaB16F10OT-1 T cell NA/NSNA/NS
28783722CRISPR-Cas9 melanomaMel6242CT-CRISPR NA/NSNA/NS
28723893CRISPR-Cas9 melanomaB16GVAX+Anti-PD1 NA/NSNA/NS
28723893CRISPR-Cas9 melanomaB16GVAX NA/NSNA/NS
25691366RNAiBreast cancerMCF7Luc-CTL assay NA/NSNA/NS
24476824shRNAmelanomaB16Primary screen NA/NSNA/NS
24476824shRNAmelanomaB16Secondary screen NA/NSNA/NS
Summary
SymbolLRP2
Namelow density lipoprotein receptor-related protein 2
Aliases gp330; megalin; Heymann nephritis antigen homolog; LRP-2; calcium sensor protein; glycoprotein 330; Low-dens ......
Chromosomal Location2q31.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets.
> Expression difference between responders and non-responders
> Mutation difference between responders and non-responders
> Expression difference between responders and non-responders
 
Points in the above scatter plot represent the expression difference of LRP2 in various data sets.
No PMID Cancer type Group Drug # Res # NRes Log2 (Fold Change) P value Anno
126997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)1412-0.2810.605
226997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)65-0.3480.695
326997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)87-0.2290.761
428552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 9160.5030.502
528552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 590.2830.89
628552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 470.7720.742
729033130MelanomaallAnti-PD-1 (nivolumab) 26232.1660.0349
829033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 15112.5010.0952
929033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 11121.8810.235
1029301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 48-1.5280.501
1129301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 2001
1229301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 28-1.0720.716
1329443960Urothelial cancerallAnti-PD-L1 (atezolizumab) 682300.3130.374
> Mutation difference between responders and non-responders
 
Points in the above scatter plot represent the mutation difference of LRP2 in various data sets.
No PMID Cancer type Group Drug # Res # NRes % Mut/Res % Mut/NRes % Diff (R vs NR) Pval Anno
125765070Non-small cell lung cancer (NSCLC)allAnti-PD-1 (pembrolizumab) 14177.111.8-4.71
225765070Non-small cell lung cancer (NSCLC)smokingAnti-PD-1 (pembrolizumab) 1031033.3-23.30.423
325765070Non-small cell lung cancer (NSCLC)non-smokingAnti-PD-1 (pembrolizumab) 41407.1-7.11
426359337MelanomaallAnti-CTLA-4 (ipilimumab) 277333.319.214.10.181
526359337MelanomaBRAFiAnti-CTLA-4 (ipilimumab) 01407.1-7.11
626359337Melanomanon-BRAFiAnti-CTLA-4 (ipilimumab) 275933.32211.30.295
726997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)211747.611.835.80.0336
826997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)86500500.0849
926997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)131146.218.2280.211
1028552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 91611.112.5-1.41
1128552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 59011.1-11.11
1228552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 472514.310.71
1329033130MelanomaallAnti-PD-1 (nivolumab) 382721.17.413.70.175
1429033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 221322.7022.70.134
1529033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 161418.814.34.51
1629301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 111307.7-7.71
1729301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 610001
1829301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 51208.3-8.31
Summary
SymbolLRP2
Namelow density lipoprotein receptor-related protein 2
Aliases gp330; megalin; Heymann nephritis antigen homolog; LRP-2; calcium sensor protein; glycoprotein 330; Low-dens ......
Chromosomal Location2q31.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of LRP2. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene.
> Lymphocyte
 
Summary
SymbolLRP2
Namelow density lipoprotein receptor-related protein 2
Aliases gp330; megalin; Heymann nephritis antigen homolog; LRP-2; calcium sensor protein; glycoprotein 330; Low-dens ......
Chromosomal Location2q31.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of LRP2. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by LRP2.
> Immunoinhibitor
> Immunostimulator
> MHC molecule
> Immunoinhibitor
 
> Immunostimulator
 
> MHC molecule
 
Summary
SymbolLRP2
Namelow density lipoprotein receptor-related protein 2
Aliases gp330; megalin; Heymann nephritis antigen homolog; LRP-2; calcium sensor protein; glycoprotein 330; Low-dens ......
Chromosomal Location2q31.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of LRP2. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene.
> Chemokine
> Receptor
> Chemokine
 
> Receptor
 
Summary
SymbolLRP2
Namelow density lipoprotein receptor-related protein 2
Aliases gp330; megalin; Heymann nephritis antigen homolog; LRP-2; calcium sensor protein; glycoprotein 330; Low-dens ......
Chromosomal Location2q31.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Distribution of LRP2 expression across immune and molecular subtypes.
> Immune subtype
> Molecular subtype
> Immune subtype
 
> Molecular subtype
 
Summary
SymbolLRP2
Namelow density lipoprotein receptor-related protein 2
Aliases gp330; megalin; Heymann nephritis antigen homolog; LRP-2; calcium sensor protein; glycoprotein 330; Low-dens ......
Chromosomal Location2q31.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Associations between LRP2 and clinical features.
> Overall survival analysis
> Cancer stage
> Tumor grade
> Overall survival
 
> Stage
 
> Grade
 
Summary
SymbolLRP2
Namelow density lipoprotein receptor-related protein 2
Aliases gp330; megalin; Heymann nephritis antigen homolog; LRP-2; calcium sensor protein; glycoprotein 330; Low-dens ......
Chromosomal Location2q31.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Drugs targeting LRP2 collected from DrugBank database.
> Drugs from DrugBank database
 

  Details on drugs targeting LRP2.
ID Name Drug Type Targets #Targets
DB00013UrokinaseBiotechLRP2, NID1, PLAT, PLAU, PLAUR, PLG, SERPINA5, SERPINB2, SERPINE1, ......10
DB00030Insulin HumanBiotechCPE, CTSD, IDE, IGF1R, IGFBP7, INSR, LRP2, NOV, PCSK1, PCSK2, RB1, ......12
DB00071Insulin PorkBiotechCPE, CTSD, HLA-DQA2, HLA-DQB1, IDE, IGF1R, IGFBP7, INSR, LRP2, NOV ......14
DB00798GentamicinSmall MoleculeDHFR, LRP22